Brief: Fusion Antibodies Completes Restructuring Process To Reduce Annualised Costs By About £2.2 Mln

Fusion Antibodies

14/08/2023 07:18

Aug 14 (Reuters) - Fusion Antibodies PLC  FAB.L :
    * FUSION ANTIBODIES  - UPDATE ON RESTRUCTURE AND COST
SAVINGS
    * FUSION ANTIBODIES PLC - COMPLETED A RESTRUCTURING PROCESS
SET
OUT AT TIME OF PLACING TO REDUCE ANNUALISED COSTS BY
APPROXIMATELY £2.2 MILLION
    * FUSION ANTIBODIES PLC - ON TRACK TO REALISE ALL INTENDED
SAVINGS
OUTLINED

Source text for Eikon:  ID:nRSN1449Ja 
Further company coverage:  FAB.L 

 ((Reuters.Briefs@thomsonreuters.com;))